FLUOROQUINOLONE- ASSOCIATED TENDON-RUPTURE: A SUMMARY OF REPORTS IN THE FOOD AND DRUG ADMINISTRATION'S (FDA'S) ADVERSE EVENT REPORTING SYSTEM

被引：1

作者：

Arabyat, R. M. ^{[1
]}

Garg, V ^{[2
]}

Raisch, D. W. ^{[3
]}

Bennett, C. ^{[4
]}

机构：

[1] Univ New Mexico, Albuqurque, NM USA

[2] Univ New Mexico, Albuquerque, NM 87131 USA

[3] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA

[4] Univ S Carolina, Columbia, SC 29208 USA

来源：

VALUE IN HEALTH | 2013年 / 16卷 / 03期

关键词：

D O I：

10.1016/j.jval.2013.03.1101

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A217 / A217

页数：1

共 50 条

[21] LEVETIRACETAM-INDUCED RHABDOMYOLYSIS: ANALYSIS OF REPORTS FROM THE FOOD AND DRUG ADMINISTRATION'S ADVERSE EVENT REPORTING SYSTEM DATABASE Reply
Casanova-Molla, J.
Valls-Sole, J.
MUSCLE & NERVE, 2017, 56 (06) : E178 - E178
[22] Descriptive analysis on disproportionate medication errors and associated patient characteristics in the Food and Drug Administration's Adverse Event Reporting System
Pera, Victor
van Vaerenbergh, Frauke
Kors, Jan A.
van Mulligen, Erik M.
Parry, Rowan
de Wilde, Marcel
Lahousse, Lies
van Der Lei, Johan
Rijnbeek, Peter R.
Verhamme, Katia M. C.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
[23] Vitiligo adverse events and associated medications as reported in the US Food and Drug Administration's Adverse Event Reporting System from 2016 to 2021
Learned, Christine
Cohen, Stephanie R.
Alsukait, Sarah
Deverapalli, Sandhya
Rosmarin, David
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (01) : 197 - 199
[24] Pharmacovigilance Analysis of the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) Events for Daprodustat
Bell, Abraham
Maddineni, Gautam
Milutinovic, Stefan
Bell, Isaac
Oliveira, Meloney
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
[25] SERIOUS ADVERSE DRUG EVENTS REPORTED TO THE FOOD AND DRUG ADMINISTRATION (FDA): ANALYSIS OF THE FDA ADVERSE EVENT REPORTING SYSTEM (FAERS) 2006-2011 DATABASE
Sonawane, K. B.
Hansen, R. A.
VALUE IN HEALTH, 2015, 18 (03) : A86 - A86
[26] Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's adverse event reporting system and review of case reports in the literature
Raisch, Dennis W.
Garg, Vishvas
Arabyat, Rasha
Shen, Xian
Edwards, Beatrice J.
Miller, Frank H.
McKoy, June M.
Nardone, Beatrice
West, Dennis P.
EXPERT OPINION ON DRUG SAFETY, 2014, 13 (01) : 15 - 23
[27] Fluoroquinolone-Associated Myasthenia Gravis ExacerbationEvaluation of Postmarketing Reports from the US FDA Adverse Event Reporting System and a Literature Review
S. Christopher Jones
Alfred Sorbello
Robert M. Boucher
Drug Safety, 2011, 34 : 839 - 847
[28] The association between ketamine and esketamine and suicidality: reports to the Food And Drug Administration Adverse Event Reporting System (FAERS)
Mcintyre, Roger S.
Mansur, Rodrigo B.
Rosenblat, Joshua D.
Teopiz, Kayla M.
Kwan, Angela T. H.
EXPERT OPINION ON DRUG SAFETY, 2024,
[29] Neoplasm Reports in Food and Drug Administration Adverse Event Reporting System Following Angiotensin Receptor Blocker Recalls
Cohen Sedgh, Robert
Moon, Jungyeon
Jackevicius, Cynthia A.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2021, 14 (08): : E007476
[30] Concomitant opioid and benzodiazepine or Z-drug use: Analysis of the Food and Drug Administration's adverse event reporting system
Nguyen, Anh Thy H.
Scheer, Darren
Schwartz, Skai
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 336 - 337

← 1 2 3 4 5 →